Kronos Bio, Inc. (KRON)

Last Closing Price: 4.95 (2022-08-10)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Kronos Bio, Inc. (KRON) had Stock-Based Compensation of $15.99M for the most recently reported fiscal quarter, ending 2022-06-30.

Figures for fiscal quarter ending 2022-06-30
Income Statement Financials
--
$-32.90M
--
--
$33.53M
$-33.53M
$0.63M
$-32.90M
$-32.90M
$-32.90M
$-32.90M
$-32.90M
$-32.90M
$-33.53M
$-32.92M
56.12M
56.12M
$-0.59
$-0.59
Balance Sheet Financials
$274.77M
$13.98M
$66.45M
$341.22M
$18.23M
--
$30.75M
$48.98M
$292.24M
$292.24M
$292.24M
56.22M
Cash Flow Statement Financials
$-46.00M
$-67.06M
$0.94M
$200.30M
$88.17M
$-112.13M
Stock-Based Compensation
$15.99M
--
--
Fundamental Metrics & Ratios
15.07
--
--
--
--
--
--
--
--
--
--
$-46.46M
--
--
--
--
--
--
--
-11.26%
-11.26%
-9.64%
-11.26%
$5.20
$-0.83
$-0.82